Bio-Rad Laboratories Class A
531 hedge funds and large institutions have $14.3B invested in Bio-Rad Laboratories Class A in 2021 Q4 according to their latest regulatory filings, with 83 funds opening new positions, 183 increasing their positions, 198 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
531
Holders Change
+27
Holders Change %
+5.36%
% of All Funds
8.2%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.09%
New
83
Increased
183
Reduced
198
Closed
42
Calls
$42.3M
Puts
$109M
Net Calls
-$66.9M
Net Calls Change
-$88.8M
Top Buyers
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
+$38.3M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$38M |
| 3 |
Morgan Stanley
New York
|
+$33.4M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$32.9M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$30.2M |
Top Sellers
| 1 |
Wells Fargo
San Francisco,
California
|
-$232M |
| 2 |
Millennium Management
New York
|
-$106M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$80.1M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$55.6M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$42.2M |
